Publications by authors named "Tracy Swan"

Claim this Profile
U
Use of dual antiretroviral therapy in individuals with different serological patterns for hepatitis B: What are the risks? What are the clinical implications?
Arda Kaya, Dominik Benke, Tracy Swan, Sven Breitschwerdt, Jan-Christian Wasmuth

HIV Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis delta in HIV/hepatitis B coinfection: A call for action.
Didem Celik, Kathrin van Bremen, Sven Breitschwerdt, Fauzi Elamouri, Tracy Swan

HIV Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The path to hepatitis C elimination: who are we leaving behind and why?
Jurgen K Rockstroh, Tracy Swan, Judy Chang, Fauzi Elamouri, Andrew R Lloyd

J Int AIDS Soc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress, Coping, and Physical Health in Caregiving.
Melissa Zajdel, Tracy Swan, Taylor Robinson, Krystyna R Keller, Lindsey Mountcastle

Transl Issues Psychol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Tracy Swan

Int J Drug Policy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection.
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Tracy Swan

Int J Drug Policy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the COVID-19 pandemic on harm reduction services in Spain.
Camila A Picchio, Jorge Valencia, Jason Doran, Tracy Swan, Marta Pastor

Harm Reduct J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global hepatitis C elimination: an investment framework.
Alisa Pedrana, Jessica Howell, Nick Scott, Sophia Schroeder, Christian Kuschel, Tracy Swan

Lancet Gastroenterol Hepatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-Led Monitoring: When Community Data Drives Implementation Strategies.
Solange Baptiste, Alain Manouan, Pedro Garcia, Helen Etya'ale, Tracy Swan

Curr HIV/AIDS Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Sophia E Schröeder, Alisa Pedrana, Nick Scott, David Wilson, Christian Kuschel, Tracy Swan

Liver Int· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Jason Grebely, Olav Dalgard, Brian Conway, Evan B Cunningham, Philip Bruggmann, Tracy Swan

Lancet Gastroenterol Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Jason Grebely, Olav Dalgard, Evan B Cunningham, Behzad Hajarizadeh, Graham R Foster, Tracy Swan

Int J Drug Policy· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
François M J Lamoury, Angelica Soker, Danica Martinez, Behzad Hajarizadeh, Evan B Cunningham, Tracy Swan

J Clin Virol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Tracy Swan

BMC Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.
Jason Grebely, Tracy Swan, Matthew Hickman, Julie Bruneau, Philip Bruggmann

J Hepatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
Tongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, Andrew Scheibe, Tracy Swan

Hepatol Med Policy· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Treatment and Persons Who Inject Drugs.
Jason Grebely, Gregory J Dore, Robert Greenwald, Tracy Swan, Soumitri Barua

Ann Intern Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries.
Nathan Ford, Stefan Wiktor, Karyn Kaplan, Isabelle Andrieux-Meyer, Andrew Hill, Tracy Swan

Int J Drug Policy· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a more accurate estimate of the prevalence of hepatitis C in the United States.
Brian R Edlin, Benjamin J Eckhardt, Marla A Shu, Scott D Holmberg, Tracy Swan

Hepatology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
Magdalena Harris, Eliot Albers, Tracy Swan

Int J Drug Policy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?
Jason Grebely, Bridget Haire, Lynn E Taylor, Paul Macneill, Alain H Litwin, Tracy Swan

J Hepatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the management of hepatitis C virus infection among people who inject drugs.
Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Tracy Swan

Int J Drug Policy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.
Soumitri Barua, Robert Greenwald, Jason Grebely, Gregory J Dore, Tracy Swan

Ann Intern Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A path to eradication of hepatitis C in low- and middle-income countries.
Camilla S Graham, Tracy Swan

Antiviral Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.
Nathan Ford, Tracy Swan, Peter Beyer, Gottfried Hirnschall, Philippa Easterbrook

J Hepatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis